Dimensional Fund Advisors LP Purchases 26,929 Shares of Azenta, Inc. (NASDAQ:AZTA)

Dimensional Fund Advisors LP lifted its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 0.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,033,171 shares of the company's stock after purchasing an additional 26,929 shares during the period. Dimensional Fund Advisors LP owned approximately 6.64% of Azenta worth $151,659,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Conestoga Capital Advisors LLC lifted its position in shares of Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after purchasing an additional 621,830 shares in the last quarter. Norges Bank acquired a new position in shares of Azenta in the fourth quarter worth $25,403,000. Schroder Investment Management Group grew its stake in Azenta by 46.7% in the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock valued at $70,183,000 after purchasing an additional 447,292 shares in the last quarter. Marshall Wace LLP purchased a new stake in shares of Azenta during the 4th quarter worth about $20,469,000. Finally, Federated Hermes Inc. lifted its holdings in shares of Azenta by 65.9% during the 4th quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock valued at $38,109,000 after buying an additional 302,786 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AZTA. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Evercore ISI raised their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Stephens reissued an "overweight" rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Finally, Needham & Company LLC upped their target price on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th.

Azenta Trading Down 1.0 %

AZTA traded down $0.27 during midday trading on Wednesday, reaching $26.34. The company's stock had a trading volume of 750,277 shares, compared to its average volume of 650,767. Azenta, Inc. has a twelve month low of $24.06 and a twelve month high of $63.58. The stock has a market cap of $1.20 billion, a P/E ratio of -8.84 and a beta of 1.66. The company has a fifty day simple moving average of $33.93 and a 200 day simple moving average of $42.88.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.